Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

BioNTech SE (22UAy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
81.40 -0.50    -0.61%
16:35:42 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 49,770
  • Bid/Ask: 81.10 / 81.40
  • Day's Range: 81.05 - 82.20
Type:  Equity
Market:  Germany
ISIN:  US09075V1026 
WKN:  A2PSR2
BioNTech 81.40 -0.50 -0.61%

22UAy Ratios

 
Use this page to view BioNTech SE key financial ratios such as their Price-to-Earnings (P/E Ratio), Earnings-Per-Share (EPS), Return-On-Investment (ROI) and others based on the latest BNTX financial reports.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 20.97 8.69
Price to Sales TTM 5.11 924.91
Price to Cash Flow MRQ 3.63 12.06
Price to Free Cash Flow TTM 3.81 10.41
Price to Book MRQ 0.96 2.91
Price to Tangible Book MRQ 1.03 4.32
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 84.29% -103.52
Gross Margin 5YA 85.36% -979.45
Operating margin TTM 25.39% -2,257.71
Operating margin 5YA -14.49% -3,283.32
Pretax margin TTM 31.06% -12,041.01
Pretax margin 5YA -10.35% -8,727.79
Net Profit margin TTM 24.36% -12,047.11
Net Profit margin 5YA -20.07% -11,227.35
   
Revenue/Share TTM 16.07 43.47
Basic EPS ANN 3.87 16.01
Diluted EPS ANN 3.83 15.32
Book Value/Share MRQ 85.17 85.32
Tangible Book Value/Share MRQ 80.35 83.7
Cash/Share MRQ 49.07 24.11
Cash Flow/Share TTM 22.6 14.57
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 4.62% -11.36
Return on Equity 5YA 32.92% 8.92
Return on Assets TTM 4.02% 2.71
Return on Assets 5YA 37.64% 10.71
Return on Investment TTM 3.81% 5.25
Return on Investment 5YA 49.58% 13.75
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ -79.64% -39.75
EPS(TTM) vs TTM 1 Yr. Ago TTM -90.03% -109.35
5 Year EPS Growth 5YA 0% 8.92
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ -65.43% 33.38
Sales (TTM) vs TTM 1 Yr. Ago TTM -77.94% 31.87
5 Year Sales Growth 5YA 97.35% 46.77
5 Year Capital Spending Growth 5YA 52.93% 14.35
   
Quick Ratio MRQ 9.04 3.95
Current Ratio MRQ 9.43 4.62
LT Debt to Equity MRQ 0.01% 9.67
Total Debt to Equity MRQ 1.08% 1.69
Efficiency    
Asset Turnover TTM 0.17 0.35
Inventory Turnover TTM 1.5 4.8
Revenue/Employee TTM 622.70K 749.61K
Net Income/Employee TTM 151.69K -279.13K
Receivable Turnover TTM 2.84 5.82
   
Dividend Yield ANN - 0.06
Dividend Yield 5 Year Avg. 5YA - 0.05
Dividend Growth Rate ANN 0% 0.12
Payout Ratio TTM - 3.21
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BNTX Price Commentary

Write your thoughts about BioNTech SE
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ali Atat
Ali Atat Jan 21, 2022 7:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Financial figures state 12$ per share per sept quarter… Dec21 quarter 8$ per share per quarter… simple math shows this stock is worth at least 300$.
Ali Atat
Ali Atat Jan 20, 2022 8:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Think long, this is 270Euro value stock
Ali Atat
Ali Atat Jan 19, 2022 8:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The drop in price has no logical explanation! This company is producing best vaccine that will long live with humanity. Its fair value today is 270 Euro! Investors are throwing away a good opportunity by selling!
Shums Cassim
Shums Cassim Nov 07, 2021 0:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price crash due to fake news of Pfizer CEO arrest? Huge buy opportunity right now.
Neja Abdualkerm
Neja Abdualkerm Oct 23, 2021 18:11
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We are Habesha kemis traditional dresses shop
Noel Tan
Noel Tan Aug 23, 2021 13:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big buy now!
Daniel Chang
Daniel Chang Aug 13, 2021 7:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good news FDA had authorised extra dose vaccine!
John HZ
Bench Aug 13, 2021 7:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not quite! Authorisation is restricted to the severely immunocompromised
Cathy Huynh
Cathy Huynh Aug 12, 2021 18:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy?
Daniel Chang
Daniel Chang Aug 12, 2021 7:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
3rd fose covid vaccine
Daniel Chang
Daniel Chang Aug 12, 2021 7:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
latest news. FDA reported to give full approval of Pfizer covid vaccine by Labor Day.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email